[1]
Luo, J. et al. 2024. Dynamic evaluation of liver fibrosis to assess hepatocellular carcinoma risk in patients with chronic hepatitis B receiving nucleoside analogs treatment. Revista do Instituto de Medicina Tropical de São Paulo. 66, (May 2024), e27. DOI:https://doi.org/10.1590/.